Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 33 checked references that resolve
resolves10.1111/j.1572-0241.2005.00253.xResponse of Hepatitis C Genotype-4 Naive Patients to 24 Weeks of Peg-Interferon-alpha2b/Ribavirin or Induction-Dose Interferon-alpha2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study
resolves10.1038/nature04082Mechanism of action of interferon and ribavirin in treatment of hepatitis C
resolves10.1056/NEJMoa020047Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
resolves10.1016/S0016-5085(03)00668-1Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.
resolves10.1053/jhep.2003.50019Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load
resolves10.1002/hep.510290424The Long–Term Outcomes of Patients With Compensated Hepatitis C Virus-Related Cirrhosis and History of Parenteral Exposure in the United States
resolves10.1002/hep.20266Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus-specific T cell response kinetics
resolves10.1053/j.gastro.2006.01.034Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response
resolves10.1055/s-2005-864781The Liver Biopsy in Chronic Hepatitis C: A View from the Other Side of the Microscope
resolves10.1002/hep.20563High‐dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C†
resolves10.1016/S0140-6736(01)06102-5Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
resolves10.1053/gast.2002.35950Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C
resolves10.1055/s-2000-9506Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
resolves10.1002/hep.21043Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.